vs
RICHARDSON ELECTRONICS, LTD.（RELL）与REGENXBIO Inc.（RGNX）财务数据对比。点击上方公司名可切换其他公司
RICHARDSON ELECTRONICS, LTD.的季度营收约是REGENXBIO Inc.的1.7倍（$52.3M vs $30.3M），RICHARDSON ELECTRONICS, LTD.净利率更高（-0.2% vs -221.3%，领先221.1%），REGENXBIO Inc.同比增速更快（43.0% vs 5.7%），RICHARDSON ELECTRONICS, LTD.自由现金流更多（$-1.7M vs $-52.8M），过去两年REGENXBIO Inc.的营收复合增速更高（39.4% vs -0.3%）
詹姆斯·理查森集团（又名JR集团）是澳大利亚私有综合企业，业务涵盖家具、酒店、房地产及零售领域，总部位于墨尔本阿伯茨福德区，全球雇员约2300人。该企业最为消费者熟知的是其分布在澳大拉西亚和中东地区机场、边境口岸的免税零售门店，在以色列是家喻户晓的企业。
REGENXBIO Inc.是一家临床阶段生物技术企业，专注于开发针对罕见及严重遗传疾病的突破性基因疗法。公司拥有专有的腺相关病毒载体技术，既向全球生物制药合作伙伴提供技术授权，也自主推进多疾病领域的基因疗法管线研发。
RELL vs RGNX — 直观对比
营收规模更大
RELL
是对方的1.7倍
$30.3M
营收增速更快
RGNX
高出37.4%
5.7%
净利率更高
RELL
高出221.1%
-221.3%
自由现金流更多
RELL
多$51.1M
$-52.8M
两年增速更快
RGNX
近两年复合增速
-0.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.3M | $30.3M |
| 净利润 | $-121.0K | $-67.1M |
| 毛利率 | 30.7% | — |
| 营业利润率 | 0.3% | -190.0% |
| 净利率 | -0.2% | -221.3% |
| 营收同比 | 5.7% | 43.0% |
| 净利润同比 | 83.9% | -31.2% |
| 每股收益（稀释后） | — | $-1.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RELLRGNX
| Q4 25 | $52.3M | $30.3M | ||
| Q3 25 | $54.6M | $29.7M | ||
| Q2 25 | — | $21.4M | ||
| Q1 25 | $53.8M | $89.0M | ||
| Q4 24 | $49.5M | $21.2M | ||
| Q3 24 | $53.7M | $24.2M | ||
| Q2 24 | — | $22.3M | ||
| Q1 24 | $52.4M | $15.6M |
净利润RELLRGNX
| Q4 25 | $-121.0K | $-67.1M | ||
| Q3 25 | $1.9M | $-61.9M | ||
| Q2 25 | — | $-70.9M | ||
| Q1 25 | $-2.1M | $6.1M | ||
| Q4 24 | $-751.0K | $-51.2M | ||
| Q3 24 | $590.0K | $-59.6M | ||
| Q2 24 | — | $-53.0M | ||
| Q1 24 | $750.0K | $-63.3M |
毛利率RELLRGNX
| Q4 25 | 30.7% | — | ||
| Q3 25 | 31.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 31.0% | — | ||
| Q4 24 | 31.0% | 70.2% | ||
| Q3 24 | 30.6% | 48.8% | ||
| Q2 24 | — | 52.5% | ||
| Q1 24 | 29.5% | 72.6% |
营业利润率RELLRGNX
| Q4 25 | 0.3% | -190.0% | ||
| Q3 25 | 1.8% | -176.3% | ||
| Q2 25 | — | -296.3% | ||
| Q1 25 | -5.1% | 13.6% | ||
| Q4 24 | -1.3% | -242.1% | ||
| Q3 24 | 0.6% | -256.6% | ||
| Q2 24 | — | -251.3% | ||
| Q1 24 | 1.9% | -408.8% |
净利率RELLRGNX
| Q4 25 | -0.2% | -221.3% | ||
| Q3 25 | 3.5% | -208.3% | ||
| Q2 25 | — | -331.8% | ||
| Q1 25 | -3.8% | 6.8% | ||
| Q4 24 | -1.5% | -241.3% | ||
| Q3 24 | 1.1% | -246.3% | ||
| Q2 24 | — | -237.7% | ||
| Q1 24 | 1.4% | -405.4% |
每股收益（稀释后）RELLRGNX
| Q4 25 | — | $-1.30 | ||
| Q3 25 | — | $-1.20 | ||
| Q2 25 | — | $-1.38 | ||
| Q1 25 | — | $0.12 | ||
| Q4 24 | — | $-0.99 | ||
| Q3 24 | — | $-1.17 | ||
| Q2 24 | — | $-1.05 | ||
| Q1 24 | — | $-1.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.1M | $230.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $158.5M | $102.7M |
| 总资产 | $201.8M | $453.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RELLRGNX
| Q4 25 | $33.1M | $230.1M | ||
| Q3 25 | $35.7M | $274.2M | ||
| Q2 25 | — | $323.3M | ||
| Q1 25 | $36.7M | $267.9M | ||
| Q4 24 | $26.6M | $234.7M | ||
| Q3 24 | $23.0M | $255.5M | ||
| Q2 24 | — | $290.4M | ||
| Q1 24 | $18.9M | $338.7M |
股东权益RELLRGNX
| Q4 25 | $158.5M | $102.7M | ||
| Q3 25 | $159.4M | $161.5M | ||
| Q2 25 | — | $213.7M | ||
| Q1 25 | $152.9M | $274.2M | ||
| Q4 24 | $156.2M | $259.7M | ||
| Q3 24 | $159.1M | $301.4M | ||
| Q2 24 | — | $348.3M | ||
| Q1 24 | $158.6M | $390.7M |
总资产RELLRGNX
| Q4 25 | $201.8M | $453.0M | ||
| Q3 25 | $200.1M | $525.2M | ||
| Q2 25 | — | $581.0M | ||
| Q1 25 | $189.8M | $490.9M | ||
| Q4 24 | $195.2M | $466.0M | ||
| Q3 24 | $197.9M | $519.1M | ||
| Q2 24 | — | $569.4M | ||
| Q1 24 | $193.6M | $629.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-99.0K | $-52.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.7M | $-52.8M |
| 自由现金流率自由现金流/营收 | -3.3% | -174.0% |
| 资本支出强度资本支出/营收 | 3.1% | 1.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $7.6M | $-126.4M |
8季度趋势，按日历期对齐
经营现金流RELLRGNX
| Q4 25 | $-99.0K | $-52.3M | ||
| Q3 25 | $1.4M | $-56.0M | ||
| Q2 25 | — | $-49.3M | ||
| Q1 25 | $4.6M | $33.6M | ||
| Q4 24 | $5.5M | $-31.6M | ||
| Q3 24 | $412.0K | $-40.5M | ||
| Q2 24 | — | $-45.5M | ||
| Q1 24 | $-2.5M | $-55.5M |
自由现金流RELLRGNX
| Q4 25 | $-1.7M | $-52.8M | ||
| Q3 25 | $342.0K | $-56.5M | ||
| Q2 25 | — | $-49.7M | ||
| Q1 25 | $4.1M | $32.6M | ||
| Q4 24 | $4.9M | $-32.7M | ||
| Q3 24 | $-514.0K | $-40.9M | ||
| Q2 24 | — | $-46.0M | ||
| Q1 24 | $-2.9M | $-56.0M |
自由现金流率RELLRGNX
| Q4 25 | -3.3% | -174.0% | ||
| Q3 25 | 0.6% | -189.9% | ||
| Q2 25 | — | -232.8% | ||
| Q1 25 | 7.5% | 36.6% | ||
| Q4 24 | 10.0% | -154.2% | ||
| Q3 24 | -1.0% | -168.9% | ||
| Q2 24 | — | -206.2% | ||
| Q1 24 | -5.6% | -358.5% |
资本支出强度RELLRGNX
| Q4 25 | 3.1% | 1.7% | ||
| Q3 25 | 1.9% | 1.7% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | 1.0% | 1.2% | ||
| Q4 24 | 1.0% | 5.1% | ||
| Q3 24 | 1.7% | 1.3% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | 0.8% | 3.6% |
现金转化率RELLRGNX
| Q4 25 | — | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.37× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RELL
| Power And Microwave Technologies Group | $35.2M | 67% |
| Canvys | $8.8M | 17% |
| Global Energy Solutions | $8.3M | 16% |
RGNX
| Novartis Gene Therapies | $24.2M | 80% |
| Nippon Shinyaku Collaboration And License Agreement | $4.3M | 14% |
| Nippon Shinyaku Services | $1.4M | 5% |
